These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 22703797)
1. Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. Barlow M; Edelman M; Glick RD; Steinberg BM; Soffer SZ J Pediatr Surg; 2012 Jun; 47(6):1223-7. PubMed ID: 22703797 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor. Okumura T; Murata Y; Hizue M; Matsuura T; Naganeo R; Kanai Y; Murase A; Sakakibara A; Fujita I; Nakao K Eur J Pharmacol; 2006 Jun; 539(1-2):125-30. PubMed ID: 16690052 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
6. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. Chandler HL; Barden CA; Lu P; Kusewitt DF; Colitz CM Mol Vis; 2007 Apr; 13():677-91. PubMed ID: 17563718 [TBL] [Abstract][Full Text] [Related]
8. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro]. Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro. Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548 [TBL] [Abstract][Full Text] [Related]
10. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors. Ding X; Zhu C; Qiang H; Zhou X; Zhou G Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L; Chen W; Xie X; He Y; Bai X Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340 [TBL] [Abstract][Full Text] [Related]
12. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel BS; Davis TW; Ornberg RL; Masferrer JL Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270 [TBL] [Abstract][Full Text] [Related]
13. Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression. Li WZ; Huo QJ; Wang XY; Xu F Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):113-9. PubMed ID: 20709621 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors. Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma. Gendy AS; Lipskar A; Glick RD; Steinberg BM; Edelman M; Soffer SZ J Pediatr Surg; 2011 Jan; 46(1):108-14. PubMed ID: 21238650 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
17. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
19. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma. Kwak YE; Jeon NK; Kim J; Lee EJ Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023 [TBL] [Abstract][Full Text] [Related]
20. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]